Financial Year |
March 31 2023 |
Monetary Funds |
142,890,655.59 |
Held-for-trading Financial Assets |
143,800,769.87 |
Notes Receivable |
15,657,244.56 |
Accounts Receivable |
85,893,656.36 |
Advances to Suppliers |
16,011,610.06 |
Other Receivables |
4,143,609.39 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
140,085,964.41 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,731,621.89 |
Total Current Assets |
551,215,132.13 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
1,113,239.88 |
Long-term Equity Investment |
-- |
Investment Properties |
9,392,465.62 |
Fixed Assetes |
335,921,616.87 |
Under-construction Projects |
19,015,059.50 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
139,137,720.26 |
R&D expenses |
68,429,933.00 |
Goodwill |
9,532,319.72 |
Long-Term Deferred and Prepaid Expenses |
2,459,022.33 |
Deferred Income Tax Assets |
15,944,137.43 |
Other Non-Current Assets |
3,522,017.18 |
Sub-Total of Non-Current Assets |
615,273,705.01 |
Total Assets |
1,166,488,837.14 |
Short-Term Loans |
-- |
Trading Financial liabilities |
10,852,129.04 |
Notes Payable |
-- |
Accounts Payable |
46,358,983.75 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
13,894,244.80 |
Taxes Payable |
12,157,237.03 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,746,410.02 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,169,684.92 |
Other Current Liabilities |
1,558,622.22 |
Sub-Total of Current Liabilities |
102,372,287.14 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,483,509.01 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
35,073,454.35 |
Total Liabilities |
137,445,741.49 |
Paid-In Capital(Or Share Stock) |
212,430,013.00 |
Capital Surplus |
231,768,822.87 |
Surplus Reserve |
61,606,860.07 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
503,108,791.65 |
Minority Stockholder's Interest |
20,024,600.55 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,009,018,495.10 |
Owner's Equity(Stockholder's Equity) |
1,029,043,095.65 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,166,488,837.14 |